These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35346194)

  • 1. Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer.
    Zhang X; Wang M; Feng J; Qin B; Zhang C; Zhu C; Liu W; Wang Y; Liu W; Huang L; Lu S; Wang Z
    J Nanobiotechnology; 2022 Mar; 20(1):166. PubMed ID: 35346194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
    Tiash S; Chowdhury EH
    J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.
    Chen Y; Bathula SR; Li J; Huang L
    J Biol Chem; 2010 Jul; 285(29):22639-50. PubMed ID: 20460382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
    Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
    J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma.
    Li X; Zhang L; Guo X; Xie F; Shen C; Jun Y; Luo C; Liu L; Yu X; Zhang Z; Wang Q; Gao Y; Xu K
    J Nanobiotechnology; 2021 Nov; 19(1):388. PubMed ID: 34823537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
    Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
    Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
    Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
    Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression.
    Zhu H; Chen X; Chen B; Chen B; Fan J; Song W; Xie Z; Jiang D; Li Q; Zhou M; Sun D; Zhao Y
    Cancer Lett; 2014 Nov; 354(1):142-52. PubMed ID: 25130172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Bivalent Aptamer-DNA Carrier-Doxorubicin Conjugates for Targeted Killing of Esophageal Squamous Cell Carcinoma Cells.
    Zhang T; Yin K; Niu X; Bai X; Wang Z; Ji M; Yuan B
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.
    Xu PY; Kankala RK; Pan YJ; Yuan H; Wang SB; Chen AZ
    Int J Nanomedicine; 2018; 13():4685-4698. PubMed ID: 30154654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.